SCHEMBL7410740

SCHEMBL7410740

O=C(OCc1cccc2ccccc12)[C@@H]1CCCN1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.54
▸ ELANE P08246 1/20 0.47
▸ HTR2C P28335 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ APOBEC3A P31941 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PARP10 Q53GL7 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ SLC1A3 P43003 1/20 0.40
▸ SLC1A2 P43004 1/20 0.40
▸ SLC1A1 P43005 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410737 0.88 EPHX1 (0.46) EPHX1ELANEHTR2CHTR2BCYP2D6
SCHEMBL29010884 0.82 MMP1 (0.44) ELANEHTR2CHTR2BCYP2D6TSHR
SCHEMBL29010885 0.82 ALDH1A1 (0.44) ELANEHTR2CHTR2BKDM4ETSHR
SCHEMBL11349211 0.79 EPHX1 (0.59) EPHX1KDM4EAPOBEC3AAPOBEC3GMEN1
SCHEMBL4069956 0.78 TSHR (0.63) ELANEHTR2CHTR2BTSHRALDH1A1
SCHEMBL630517 0.78 TSHR (0.63) ELANEHTR2CHTR2BTSHRALDH1A1
SCHEMBL693351 0.78 TSHR (0.63) ELANEHTR2CHTR2BTSHRALDH1A1
SCHEMBL12869701 0.78 ALDH1A1 (0.45) ELANEHTR2CHTR2BKDM4ETSHR
SCHEMBL8304059 0.77 HTR2C (0.55) HTR2CHTR2BKDM4EMEN1KMT2A
SCHEMBL8304057 0.77 HTR2C (0.55) HTR2CHTR2BKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1012180-A2 HEPATITIS C INHIBITOR PEPTIDE ANALOGUES BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2000-06-28 — — EP disclosed
EP-1003775-A2 HEPATITIS C INHIBITOR PEPTIDES BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2000-05-31 — — EP disclosed
WO-1999007733-A2 HEPATITIS C INHIBITOR PEPTIDES BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1999-02-18 — — WO disclosed
WO-1999007734-A2 HEPATITIS C INHIBITOR PEPTIDE ANALOGUES BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1999-02-18 — — WO disclosed
Send feedback